Replimune Group Inc.

NASDAQ: REPL · Real-Time Price · USD
5.55
0.20 (3.74%)
At close: Aug 15, 2025, 3:59 PM
5.60
0.81%
After-hours: Aug 15, 2025, 07:57 PM EDT

Replimune Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
n/a 1.47M n/a n/a n/a 4.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
1.67M 736K 1M 900K 736K 655K 700K 700K 621K 528K 1.29M 1.22M 1.23M 1.16M 1.16M 1.14M 1.13M 1.1M n/a n/a n/a
Gross Profit
-1.67M 736K -1M -900K -736K 3.39M -700K -700K -621K -528K -1.29M -1.22M -1.23M -1.16M -1.16M -1.14M -1.13M -1.1M n/a n/a n/a
Operating Income
-90.42M -79.33M -66.02M -58.92M -57.37M -58.76M -56.54M -63.83M -55.65M -52.99M -41.63M -41.58M -40.88M -31.99M -29.7M -29.25M -27.38M -22.18M -20.27M -19.66M -17.83M
Interest Income
n/a 5.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-86.69M -74.24M -65.77M -53.05M -53.77M -55.14M -50.65M -60.24M -49.35M -48.95M -39.69M -43.1M -42.25M -31.7M -29.67M -29.36M -27.31M -21.5M -21.78M -20.09M -17.49M
Net Income
-86.69M -74.13M -66.34M -53.05M -53.77M -55.08M -51.12M -60.04M -49.55M -49.24M -39.69M -43.1M -42.25M -31.7M -29.67M -29.36M -27.31M -21.5M -21.78M -20.09M -17.49M
Selling & General & Admin
32.58M 25.35M 18.02M 15.47M 14.39M 16.18M 13.69M 14.73M 15.21M 15.04M 11.37M 12.74M 11.4M 10.25M 10.35M 9.35M 8.83M 5.96M 5.95M 5.61M 5.68M
Research & Development
57.84M 53.98M 48M 43.45M 42.97M 42.58M 42.85M 49.1M 40.44M 37.95M 30.26M 28.83M 29.48M 21.74M 19.35M 19.9M 18.55M 16.23M 14.32M 14.05M 12.16M
Other Expenses
n/a -3K n/a n/a n/a n/a n/a n/a 1.37M -1.15M 147K -2.66M -2.02M -210K -241K -356K -252K 334K -454K -517K -28K
Operating Expenses
90.42M 79.33M 66.02M 58.92M 57.37M 58.76M 56.54M 63.83M 55.26M 52.11M 41.02M 41.01M 40.02M 31.06M 28.96M 28.52M 26.59M 21.37M 19.73M 18.91M 17.15M
Interest Expense
2M 1.99M 1.98M 1.97M 1.96M 1.95M 1.55M 1.5M 1.66M 1.57M 1.49M 550K 552K 553K 555K 557K 558K 560K 807K 848K 845K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
90.42M 79.33M 66.02M 58.92M 57.37M 58.76M 56.54M 63.83M 55.26M 52.11M 41.02M 41.01M 40.02M 31.06M 28.96M 28.52M 26.59M 21.37M 19.73M 18.91M 17.15M
Income Tax Expense
-420K -107K 575K -408K -438K -65K 473K -201K 201K 712K n/a n/a n/a n/a n/a 201K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
91.52M 80.56M 83.5M 78.57M 69.19M 61.42M 66.65M 66.58M 66.37M 56.68M 57.86M 54.77M 54.21M 47.34M 52.32M 52.08M 51.91M 46.57M 49.38M 44.02M 39.86M
Shares Outstanding (Diluted)
91.52M 80.56M 83.5M 78.57M 69.19M 61.42M 66.65M 66.58M 66.37M 56.68M 57.86M 54.77M 54.21M 47.34M 52.32M 52.08M 51.91M 46.57M 49.38M 44.02M 39.86M
EPS (Basic)
-0.95 -0.96 -0.79 -0.68 -0.78 -0.9 -0.77 -0.9 -0.75 -0.87 -0.69 -0.79 -0.78 -0.67 -0.57 -0.56 -0.53 -0.46 -0.44 -0.46 -0.44
EPS (Diluted)
-0.95 -0.96 -0.79 -0.68 -0.78 -0.9 -0.77 -0.9 -0.75 -0.87 -0.69 -0.79 -0.78 -0.67 -0.57 -0.56 -0.53 -0.46 -0.44 -0.46 -0.44
EBITDA
-83.82M -71.95M -63.16M -50.59M -51.51M -57.38M -55.45M -62.73M -47.47M -47.74M -37.52M -41.58M -40.88M -30.91M -28.7M -28.38M -26.42M -20.65M -20.52M -18.97M -16.34M
EBIT
-84.7M -72.8M -64.16M -51.49M -52.25M -58.09M -56.13M -63.39M -47.7M -47.38M -38.2M -43.13M -42.55M -31.14M -29.12M -28.8M -26.75M -20.94M -20.98M -19.25M -16.65M
Depreciation & Amortization
873K 848K 1M 900K 736K 705K 675K 654K 621K 528K 1.29M 1.22M 1.23M 1.16M 1.16M 1.14M 1.13M 1.1M 401K 425K 391K